Hepatitis C virus infection among HIV-1 infected individuals from northern Mexico

Hepatology Research

Volumn 37, Issue 5, 2007, Pages 311-316

  Rivas Estilla, Ana M ^a,b   Ramírez Valles, Eda ^a   Martinez Hernández, Ramón ^a   Charles Niño, Claudia ^a   Ramírez Camacho, Ericka ^b   Rositas Noriega, Felix ^b   Garza Rodriguez, Maria L ^a   Barrera Saldaña, Hugo A ^a   Trujillo Murillo, Karina ^a   Ramos Jimenez, Javier ^b  

^a School of Medicine   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

HCV; HCV genotypes; HIV 1; HIV 1 HCVcoinfection

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; COMPLEMENTARY DNA; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BISEXUALITY; BLOOD TRANSFUSION; COMORBIDITY; DISEASE ASSOCIATION; DNA SYNTHESIS; FEMALE; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEXICO; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; RNA ISOLATION; SERODIAGNOSIS; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SUPERINFECTION;

EID: 34247219772     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00035.x     Document Type: Article

References (29)

1. Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut 2002; 51: 601-8.
2. Perez-Cano R, Fernandez-Gutierrez C, Lopez-Suarez A, Mira J, Giron-Gonzalez JA. Factors related to the chronicity and evolution of hepatitis C infection in patients co-infected by the human immunodeficiency virus. Clin Microbiol Infect 2002; 8: 589-97.
3. Anderson KB, Guest JL, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 2004; 39: 1507-13.
4. Asmuth DM, Busch MP, Laycock ME et al. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection. Antiviral Res 2004; 63: 123-31.
5. Aranzabal L, Casado JL, Moya J et al. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2005; 40: 588-93.
6. Laguno M, Sanchez-Tapias JM, Murillas J et al. Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection. Enferm Infect Microbiol Clin 2005; 23: 32-40.
7. Lewden C, Salmon D, Morlat P et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: Emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34: 121-30.
8. Mendes-Correa MC, Barone AA. Hepatitis C in patients co-infected with human immunodeficiency virus. A review and experience of a Brazilian ambulatory. Rev Inst Med Trop Sao Paulo 2005; 47: 59-64.
9. de los Angeles Pando M, Biglione MM, Toscano MF et al. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina. Am J Trop Med Hyg 2004; 71: 153-9.
10. Soto-Ramirez LE, Perez-Saleme L, Hernandez-Tepichin G et al. Antiretroviral treatment guide for adult people living with HIV/AIDS. Rev Invest Clin 2004; 56: 253-71.
11. Joint United Nations Programme on HIV/AIDS UNAIDS. International Organization for Migration IOM. Migration and AIDS. Int Migr 1998; 36: 445-68.
12. Uribe Zuniga P. The UNAIDS challenges for the next millennium and the participation of Mexico. Salud Publica Mex 1999; 41: 492-4.
13. Mohsen A, Murad S, Easterbrook P. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. HIV Med 2005; 6: 206-15.
14. Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr 2003; 33: 356-64.
15. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med 2004; 19: 357-65.
16. Pallas JR, Farinas-Alvarez C, Prieto D, Delgado-Rodriguez M. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 1999; 15: 699-704.
17. Mendel I, Clotteau L, Lambert S, Buffet-Janvresse C. Hepatitis C virus infection in an HIV-positive population in Normandy: Antibodies, HCV RNA and genotype prevalence. J Med Virol 1995; 47: 231-6.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
19. Simmonds P, Buch J, Combet C et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-73.
20. World Health Organization. Hepatitis C: Global prevalence (update). Wkly Epidemiol Rec 2000; 75: 18-20.
21. Fainboim H, Gonzalez J, Fassio E et al. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 1999; 6: 53-7.
22. Vogler IH, Nishiya A, Morimoto HK et al. Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002. Rev Inst Med Trop Sao Paulo 2004; 46: 303-8.
23. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES, Hemophilia Growth and Development Study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis 2005; 191: 4-10.
24. Caudai C, Pianese M, Zacchini F, Toti M, Zazzi M, Valensin PE. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype. J Clin Virol 2005; 32: 151-5.
25. Matthews-Greer JM, Caldito GC, Adley SD et al. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol 2001; 8: 690-4.
26. Antonucci G, Girardi E, Cozzi-Lepri A et al. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Clin Infect Dis 2005; 40: E101-9.
27. Mendez-Sanchez N. Epidemiology of hepatitis C. Rev Gastroenterol Mex 2002; 67 (Suppl 2): S13-16.
28. Uribe M, Mendez-Sanchez N. Hepatitis C in Mexico. Rev Gastroenterol Mex 2002; 67 (Suppl 2): S7-8.
29. Mendez-Sanchez N, Uribe M. National consensus on hepatitis C: conclusions. Rev Invest Clin 2002; 54: 559-68.